Diagnostics
Todos Medical Ltd. announced that the Company has entered into a non-binding Memorandum of Understanding with Orot+, the operational division of Orot-Luces, to expand their existing launch and distribution partnership for the commercial sale of Todos’ early breast cancer detection blood tests TM-B1 and TM-B2 into Japan.
In China, much like the United States, it is incredibly difficult to obtain a patent for a diagnostic method.
Biopharma companies are working with diagnostic companies to develop companion diagnostic tests to go along with specific therapies, often cancer drugs.
Owlstone Medical announced the introduction of a new ReCIVA® Breath Sampler and CASPERTM Portable Air Supply, designed to support internal biomarker discovery programs and those of academic and biopharma clients, and to measure levels of known volatile organic compounds on breath.
True Diagnostics, Inc. and Veravas announced their Strategic Alliance in the commercialization of VeraTest Biotin, a portable and easy-to-use digital qualitative test that can rapidly screen patient samples to determine if significant biotin is present, helping safeguard against potential biotin interference.
More Women May Benefit from Hereditary Cancer Risk Assessment and Genetic Testing
Diagnostica Stago, introduces the STA Workcell Max, a transformative specimen processing platform designed to meet the rigorous requirements of efficient hemostasis testing.
Oxford Immunotec Global PLC announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin, Chief Financial Officer, will be participating in two upcoming investor conferences.
Singapore molecular diagnostics groups INEX Innovations Exchange Pte. Ltd. (INEX) and Nova Satra Dx Pte. Ltd. (Nova Satra) announced the merger of the two companies to create INEX INNOVATE.
The Eastern Pathology Alliance (EPA) announces today that it is to offer Hepatitis C genotyping testing to the wider NHS nationally leveraging its investment in next generation sequencing assays.
PRESS RELEASES